Status:
COMPLETED
New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-12 years
Brief Summary
Computerized continuous performance tests (CPT) considered the "gold standard" for diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD. This type of tests are based mainly on visual performan...
Detailed Description
Computerized continuous performance tests (CPT) considered the "gold standard" for diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) and are widely used. This type of tests measures the nu...
Eligibility Criteria
Inclusion
- diagnosis of ADHD by the "gold standard" method
Exclusion
- Chronic use of medications, Psychiatric disorder, Abnormal cognitive function
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00646464
Start Date
February 1 2008
End Date
December 1 2010
Last Update
March 1 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuro-Pediatric Unit, Hadassah-Hebrew University Medical Center Mount Scopus
Jerusalem, Israel, 91240
2
Neuro-Pediatric Unit, Hadassah-Hebrew University Medical Center
Jerusalem, Israel, 91240